文献速递眼底病与葡萄膜炎

TIE2 被鉴定为新生血管性年龄相关性黄斑变性与息肉状脉络膜血管病变的易感基因

Identification of TIE2 as a susceptibility gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
PubMed 文献 · Br J Ophthalmol · 2020-03-09

本研究在2343名受试者(香港、汕头和日本大阪三个队列)中分析了TIE2基因的单核苷酸多态性与新生血管性年龄相关性黄斑变性(nAMD)及息肉状脉络膜血管病变(PCV)的关联。Meta分析显示rs625767与nAMD、PCV及两者合并均显著相关,提示TIE2是nAMD和PCV的易感基因。

要点

  • TIE2基因rs625767与nAMD显著相关(p=0.01;OR=0.82,95%CI 0.70-0.96)。
  • rs625767与PCV显著相关(p=0.02;OR=0.83,95%CI 0.71-0.97)。
  • rs625767与nAMD和PCV合并分析显著相关(p=0.002;OR=0.82,95%CI 0.72-0.93)。

核心结论

  • TIE2是日本和中国人群中nAMD和PCV的新型易感基因。

研究设计与样本

  • 研究纳入2343名受试者,包括香港华人队列(214例nAMD、236例PCV、433例对照)、汕头华人队列(189例nAMD、187例PCV、531例对照)和大阪日本队列(192例nAMD、204例PCV、157例对照)。
  • 对单个和合并队列进行SNP-疾病关联分析。

主要发现

  • 在香港队列中,两个SNP(rs625767和rs2273717)显示与nAMD和PCV提示性关联。
  • 涉及所有三个队列的Meta分析中,rs625767与nAMD显著相关(p=0.01;OR=0.82,95%CI 0.70至0.96;I2=0%)。
  • rs625767与PCV显著相关(p=0.02;OR=0.83,95%CI 0.71至0.97;I2=27%)。
  • rs625767与nAMD和PCV合并显著相关(p=0.002;OR=0.82,95%CI 0.72至0.93;I2=0%),队列间异质性低。

关键数值与推荐

  • rs625767与nAMD关联:p=0.01;OR=0.82,95%CI 0.70至0.96;I2=0%。
  • rs625767与PCV关联:p=0.02;OR=0.83,95%CI 0.71至0.97;I2=27%。
  • rs625767与nAMD和PCV合并关联:p=0.002;OR=0.82,95%CI 0.72至0.93;I2=0%。

临床怎么用

  • TIE2基因变异可能作为nAMD和PCV的遗传易感标志物,但需在更多人群中验证。
  • 对于nAMD和PCV患者,可考虑TIE2基因rs625767的检测以评估遗传风险。

局限性

  • 研究仅在日本和中国人群中开展,需在其他人群中进行进一步研究确认TIE2的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The endothelial and cell-specific angiopoietin-Tie pathway plays an important regulatory role in angiogenesis. In this study, we investigated the associations of the TIE2 (tyrosine kinase, endothelial, TEK) gene with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV), using haplotype-tagging single-nucleotide polymorphisms (SNPs) analysis. METHODS: This study involved totally 2343 subjects, including a Hong Kong Chinese cohort (214 nAMD patients, 236 PCV patients and 433 control subjects), a Shantou Chinese cohort (189 nAMD patients, 187 PCV patients and 531 control subjects) and an Osaka Japanese cohort (192 nAMD patients, 204 PCV patients and 157 control subjects). Thirty haplotype-tagging SNPs in TIE2 were genotyped in the Hong Kong cohort using TaqMan technology. Two SNPs (rs625767 and rs2273717) showing association in the Hong Kong cohort were genotyped in the Shantou and Osaka cohorts. The SNP-disease association of individual and pooled cohorts were analysed. RESULTS: Two SNPs (rs625767 and rs2273717) showed suggestive association with both nAMD and PCV in the Hong Kong cohort. In the meta-analysis involving all the three cohorts, rs625767 showed significant associations with nAMD (p=0.01; OR=0.82, 95% CI 0.70 to 0.96; I2=0%), PCV (p=0.02; OR=0.83, 95% CI 0.71 to 0.97; I2=27%) and pooled nAMD and PCV (p=0.002; OR=0.82, 95% CI 0.72 to 0.93; I2=0%), with low inter-cohort heterogeneities. CONCLUSION: This study revealed TIE2 as a novel susceptibility gene for nAMD and PCV in Japanese and Chinese. Further studies in other populations are warranted to confirm its role.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chen ZJ, Ma L, Brelen ME, et al. Identification of TIE2 as a susceptibility gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Br J Ophthalmol. 2020. PMID: 32152144. doi:10.1136/bjophthalmol-2019-315746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。